Evidence map›Paper›PMID 32005776›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2020

PET/CT Imaging with an

Patricia M R Pereira, Sheryl Roberts, Flávio Figueira, João P C Tomé, Thomas Reiner, Jason S Lewis

Open access · hybridAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Galectin expression detected byEuropean journal of nuclear medicine and molecular imaging · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Patricia M R PereiraDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Sheryl RobertsDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Flávio FigueiraQOPNA and LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Aveiro, Portugal.
João P C ToméCQE and Departamento de Engenharia Química, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal.
Thomas ReinerDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Jason S LewisDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York lewisj2@mskcc.org.
Memorial Sloan Kettering Cancer Center · USInstituto Politécnico de Lisboa · PTRede de Química e Tecnologia · PT

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Leveraging Pb-203/212 for the Theranostic Imaging and Therapy of Prostate CancerR35CA232130 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI LEWIS, JASON S. · 2019 to 2025
$8.2M
NCI NIH HHS P30 CA008748NCI NIH HHS R35 CA232130
6 · The paper itself

Abstract

Galectins are carbohydrate-binding proteins overexpressed in bladder cancer (BCa) cells. Dendritic galactose moieties have a high affinity for galectin-expressing tumor cells. We radiolabeled a dendritic galactose carbohydrate with

Indexed as

Gene Expression Regulation, NeoplasticPositron Emission Tomography Computed TomographyAnimalsCell Line, TumorFluorine RadioisotopesGalactoseGalectin 1HumansIsotope LabelingMiceRadiochemistryTissue DistributionUrinary Bladder NeoplasmsFluorine-18Fluorine RadioisotopesGalactoseGalectin 118F-radiochemistrybladder cancerdendritic carbohydrategalectinsPET/CT imaging

Identifiers

PMID32005776
PMCPMC7456169
OpenAlexW3004371811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.